|
KMID : 0939920130450040349
|
|
대한암학회지
2013 Volume.45 No. 4 p.349 ~ p.353
|
|
|
Sunitinib Treatment for Metastatic Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease
|
|
Kim Ho-Cheol
Lee Jung-Su
Kim Sang-Hyung
So Hoon-Sub
Woo Chang-Yoon
Lee Jae-Lyun
|
|
|
Abstract
|
|
|
|
Von Hippel-Lindau (VHL) disease is an autosomal dominant disease that produces a variety of tumors and cysts in the central nervous system and visceral organs, including renal cell carcinoma (RCC). RCC in patients with VHL disease does not frequently metastasize, therefore, the response to treatment and prognosis of metastatic RCC developed in patients with VHL disease has not been reported. Sunitinib is an oral, multitargeted receptor tyrosine kinase inhibitor with antiangiogenic and antitumor activity. Here, we report on four patients with metastatic RCC in VHL disease who received sunitinib and achieved partial responses that have lasted for a prolonged period of time.
|
|
|
KEYWORD
|
|
|
Von Hippel-Lindau disease, Neoplasm metastasis, Renal cell carcinoma, Sunitinib
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|